Pharma Journalist 8801 posts 0 comments

Merck, known as MSD outside the United States and Canada, announced that the pivotal Phase 3 KEYNOTE-355 trial investigating KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with…
Read More...

OSE Immunotherapeutics announced a new collaboration agreement with deep technology innovative start-up MAbSilico, located in Tours, France, to use artificial intelligence (AI)-based…
Read More...

Dr. Reddy’s Laboratories Ltd. announced that it has entered into a definitive agreement with Wockhardt Limited to acquire select divisions of its branded generics business in India and…
Read More...

ALX Oncology announced the closing of a $105 million Series C equity financing. Vivo Capital was the lead investor with other new investors including funds managed by Logos Capital,…
Read More...

Novartis announced that the US Food and Drug Administration (FDA) accepted and granted Priority Review to capmatinib’s (INC280) New Drug Application (NDA). Capmatinib is a MET inhibitor…
Read More...

Cannabics Pharmaceuticals Inc. announced that it has signed a Memorandum Of Understanding with RCK Medical Cannabis to develop cannabis chemovars targeted to treat gastro intestinal…
Read More...

The 7th annual Pre-filled Syringes East Coast conference and exhibition is returning to Boston USA, in April. SMi Group are delighted to have Michael Song, Senior Manager, Dosage Form…
Read More...

SMi reports: Registration is now open for the Pre-Filled Syringes West Coast Conference, which will convene in London on 14th-15th June 2021. SMi Group are delighted to announce that…
Read More...

Astellas Pharma Inc. and Pfizer Inc. announced results of the final overall survival (OS) analysis from the Phase 3 PROSPER trial, which evaluated XTANDI (enzalutamide) plus androgen…
Read More...

Bayer AG announced that it entered into a definitive agreement to transfer a large part of its Berlin-based small molecule research unit to Nuvisan, an international service provider…
Read More...